Stock Price
0.28
Daily Change
-0.01 -1.79%
Monthly
-12.70%
Yearly
17.02%
Q3 Forecast
0.28

Paradigm Biopharmaceuticals reported AUD6.36M in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Avita Medical AUD 28.36M 2.44M Dec/2024
Medical Developments International AUD 19.8M 9.46M Dec/2024
Neuren Pharmaceuticals AUD 17.41M 2.86M Dec/2024
Pacific Edge NZD 26.27M 12.77M Sep/2024
PYC Therapeutics AUD 38.58M 20.29M Dec/2024
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024